Your browser doesn't support javascript.
loading
A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function.
Wlodek, E; Kirkpatrick, R B; Andrews, S; Noble, R; Schroyer, R; Scott, J; Watson, C J E; Clatworthy, M; Harrison, E M; Wigmore, S J; Stevenson, K; Kingsmore, D; Sheerin, N S; Bestard, O; Stirnadel-Farrant, H A; Abberley, L; Busz, M; DeWall, S; Birchler, M; Krull, D; Thorneloe, K S; Weber, A; Devey, L.
Afiliación
  • Wlodek E; GlaxoSmithKline, Clinical Unit Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Kirkpatrick RB; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Andrews S; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Noble R; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Schroyer R; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Scott J; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Watson CJE; JMS Statistics Ltd, Pinner, United Kingdom.
  • Clatworthy M; University of Cambridge and the NIHR Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge, Cambridge, United Kingdom.
  • Harrison EM; University of Cambridge and the NIHR Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge, Cambridge, United Kingdom.
  • Wigmore SJ; Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • Stevenson K; Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • Kingsmore D; Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Sheerin NS; Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Bestard O; Newcastle Biomedical Research Centre and the NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation, Newcastle University, Newcastle, United Kingdom.
  • Stirnadel-Farrant HA; L'Hospitalet de Llobregat, Bellvitge University Hospital, Kidney Transplant Unit, Barcelona, Spain.
  • Abberley L; GlaxoSmithKline, R&D, Stevenage, United Kingdom.
  • Busz M; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • DeWall S; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Birchler M; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Krull D; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Thorneloe KS; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Weber A; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
  • Devey L; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
PLoS One ; 16(3): e0247972, 2021.
Article en En | MEDLINE | ID: mdl-33684160
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Riñón / Interleucina-18 / Funcionamiento Retardado del Injerto / Lesión Renal Aguda / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Riñón / Interleucina-18 / Funcionamiento Retardado del Injerto / Lesión Renal Aguda / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido